Hope for high-risk chronic lymphocytic leukemia relapsing after allogeneic stem-cell transplantation

J Clin Oncol. 2015 May 10;33(14):1527-9. doi: 10.1200/JCO.2014.60.3282. Epub 2015 Apr 13.

Authors

Emili Montserrat¹, Peter Dreger²

Affiliations

¹ Hospital Clínic, University of Barcelona; European Research Initiative on CLL, Barcelona, Spain emontse@clinic.ub.es.
² University of Heidelberg, Heidelberg, Germany; and European Society for Blood and Marrow Transplantation, Lymphoma Working Party, Paris, France.

PMID: 25870086
DOI: 10.1200/JCO.2014.60.3282

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / surgery*
Male
Pyrazoles / therapeutic use*
Pyrimidines / therapeutic use*
Stem Cell Transplantation*

Substances

Antineoplastic Agents
Pyrazoles
Pyrimidines